- Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
- Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
- Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
- Teleflex to Present at the BofA Securities 2024 Health Care Conference
- Teleflex Announces First Quarter 2024 Earnings Conference Call Information
- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
- Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
- Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
More ▼
Key statistics
As of last trade, Teleflex Inc (TFX:NYQ) traded at 202.12, 13.79% above the 52 week low of 177.63 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 201.19 |
---|---|
High | 206.52 |
Low | 199.12 |
Bid | 202.01 |
Offer | 202.27 |
Previous close | 198.73 |
Average volume | 434.77k |
---|---|
Shares outstanding | 47.10m |
Free float | 46.98m |
P/E (TTM) | 31.77 |
Market cap | 9.36bn USD |
EPS (TTM) | 6.26 USD |
Annual div (ADY) | 1.36 USD |
---|---|
Annual div yield (ADY) | 0.68% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of May 03 2024 17:55 BST.
More ▼